KKR is set to acquire Medicover AB’s Indian healthcare business in a transaction valued at about $1.5 billion. The deal would expand the global investment firm’s presence in India’s hospital sector as healthcare spending increases.
The transaction includes the sale of the entire stake held by Medicover India’s existing shareholders. KKR will also commit fresh capital to support the business’s expansion and help repay debt.
Overall spending by KKR is expected to total roughly Rs 13,000 crore to Rs 14,000 crore. About Rs 3,000 crore to Rs 4,000 crore of that amount is expected to be directed toward fresh capital for growth and debt repayment.
The proposed acquisition would mark KKR’s third hospital deal in India in three years, underlining its focus on the country’s expanding healthcare market.
